Detalles de la búsqueda
1.
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder.
J Clin Psychopharmacol
; 39(3): 203-209, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30946704
2.
Cognitive behavioral therapy delivered via digital mobile application for the treatment of type 2 diabetes: Rationale, design, and baseline characteristics of a randomized, controlled trial.
Clin Cardiol
; 45(8): 850-856, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778834
3.
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder.
J Clin Psychiatry
; 79(4)2018 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873953
4.
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study.
Curr Med Res Opin
; 34(4): 633-642, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29343128
5.
Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.
Schizophr Res
; 174(1-3): 93-98, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27188270
6.
Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies.
Schizophr Res
; 174(1-3): 82-92, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27157799
7.
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants.
J Clin Psychiatry
; 76(9): 1224-31, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26301701
8.
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study.
J Clin Psychiatry
; 76(9): 1232-40, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26301771
9.
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Am J Psychiatry
; 172(9): 870-80, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25882325
10.
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia.
Schizophr Res
; 164(1-3): 127-35, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682550
11.
Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Curr Med Res Opin
; 30(12): 2399-408, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25133963
12.
Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92].
Schizophr Res
; 190: 191-194, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28351543
Resultados
1 -
12
de 12
1
Próxima >
>>